Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
XPEV | -<0.01% | $9.76B | +18.74% | 0.00% |
CYTK | <0.01% | $5.34B | -44.29% | 0.00% |
CCAP | -<0.01% | - | - | 8.74% |
AMRC | 0.01% | $1.26B | +0.89% | 0.00% |
LMT | 0.02% | $114.83B | +5.81% | 2.62% |
CASI | -0.03% | $34.04M | -52.88% | 0.00% |
AEE | -0.03% | $23.86B | +25.54% | 2.96% |
NFG | 0.04% | $5.91B | +32.45% | 3.10% |
IMO | -0.04% | $35.10B | +16.40% | 2.60% |
BBD | -0.05% | $10.22B | -35.28% | 2.09% |
RDWR | -0.05% | $882.96M | +25.70% | 0.00% |
ADC | -0.06% | $7.31B | +13.24% | 4.13% |
MAIN | 0.06% | $5.19B | +38.07% | 4.92% |
GOOS | -0.06% | $1.02B | -12.72% | 0.00% |
SR | 0.07% | $3.90B | +14.31% | 4.47% |
NERV | 0.08% | $14.86M | -69.42% | 0.00% |
MTN | -0.08% | $6.88B | -13.30% | 4.75% |
BCAN | 0.08% | $38.37M | -99.56% | 0.00% |
MNSO | -0.09% | $7.23B | +5.06% | 1.19% |
GORV | 0.10% | $86.69M | -85.22% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
SCHL | 35.63% | $558.93M | -46.59% | 3.96% |
IIPR | 34.49% | $1.88B | -29.25% | 10.90% |
RXST | 29.29% | $1.21B | -33.64% | 0.00% |
NVO | 25.65% | $271.01B | -23.67% | 1.74% |
KEX | 25.31% | $6.08B | +37.74% | 0.00% |
DGII | 23.87% | $1.09B | +26.77% | 0.00% |
SPNT | 23.50% | $2.35B | +31.85% | 0.00% |
HUBG | 23.26% | $2.76B | +2.67% | 1.09% |
ODFL | 22.85% | $39.20B | -4.06% | 0.69% |
AEIS | 22.79% | $4.45B | +15.10% | 0.33% |
BCC | 22.47% | $4.75B | -2.48% | 0.64% |
CTS | 22.34% | $1.53B | +22.36% | 0.31% |
ESAB | 22.27% | $7.26B | +43.74% | 0.24% |
GXO | 21.86% | $5.20B | -24.27% | 0.00% |
ARCB | 21.81% | $2.35B | -13.46% | 0.46% |
TNC | 21.80% | $1.57B | -8.50% | 1.34% |
CDRE | 21.78% | $1.34B | +1.44% | 1.04% |
ECPG | 21.71% | $1.11B | -4.65% | 0.00% |
SCSC | 21.69% | $1.17B | +33.82% | 0.00% |
KWR | 21.67% | $2.35B | -32.91% | 1.38% |
Yahoo
NORCROSS, Ga., Jan. 10, 2025 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today announced that the top-line results of the NAVIGATE trial in patients with MASH cirrhosis and portal hypertension will be presented during the 2025 MASH-TAG Conference, being held January 9-11, 2025 in Park City, Utah. Additionally, Company’s executive leadership will be hosting one-on-one meetings in San Franscico January 13-16,
Finnhub
Spanish Broadcasting System Inc - Class A is expected to report for 3Q. Spire Global Inc is expected to report $-0.40 for 3Q. Talis Biomedical Corp is expected to report for 3Q. ...
Finnhub
NORCROSS - Galectin Therapeutics, Inc. , the leading developer of therapeutics that target galectin proteins, today announced results from its global clinical trial NAVIGATE evaluating belapectin in...
SeekingAlpha
Investors will be looking to durable goods, new-home sales data and earnings season winds down.
Yahoo
Cyngn (CYN) said Friday that it priced a follow-on offering and plans to use the gross proceeds of a
Finnhub
Galectin Therapeutics Announces Top-Line Results of NAVIGATE Clinical Trial Evaluating Belapectin in Patients with Cirrhotic Portal Hypertension Caused by MASH ...
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
TPIC | -25.49% | $69.92M | -47.50% | 0.00% |
CLW | -19.93% | $472.18M | -15.15% | 0.00% |
AADI | -17.64% | $73.92M | +82.62% | 0.00% |
VSTA | -15.22% | $189.21M | -43.81% | 0.00% |
BB | -14.98% | $2.37B | +17.65% | 0.00% |
SHLS | -14.91% | $946.85M | -56.87% | 0.00% |
SJM | -14.61% | $10.84B | -20.48% | 4.17% |
CMTL | -13.79% | $81.55M | -63.87% | 0.00% |
ASPS | -13.19% | $19.06M | -72.55% | 0.00% |
CYD | -12.55% | $415.94M | +13.11% | 3.76% |
AQB | -12.25% | $2.97M | -64.07% | 0.00% |
AVO | -12.22% | $874.38M | +25.05% | 0.00% |
NFE | -12.17% | $3.65B | -58.99% | 1.30% |
KNTK | -12.15% | $3.70B | +87.13% | 4.78% |
FNKO | -11.82% | $701.21M | +95.01% | 0.00% |
GL | -11.73% | $9.57B | -4.97% | 0.83% |
K | -11.58% | $28.07B | +50.41% | 2.78% |
VUZI | -11.51% | $216.43M | +66.10% | 0.00% |
TEVA | -11.51% | $23.80B | +90.73% | 0.00% |
SIRI | -11.26% | $7.23B | -58.78% | 1.60% |
Current Value
$1.201 Year Return
Current Value
$1.201 Year Return
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
QQA | 48.70% | $145.15M | 0% |
RSPA | 42.65% | $268.92M | 0% |
EFAA | 27.84% | $102.38M | 0% |
XSMO | 20.48% | $1.39B | 0.39% |
CALF | 20.41% | $7.87B | 0.59% |
SLYG | 20.08% | $3.59B | 0.15% |
IJT | 19.85% | $6.40B | 0.18% |
SNSR | 19.58% | $227.38M | 0.68% |
XSVM | 19.51% | $754.37M | 0.37% |
XSLV | 19.42% | $288.96M | 0.25% |
IDMO | 19.31% | $298.61M | 0.25% |
EES | 19.07% | $649.59M | 0.38% |
AVUV | 19.01% | $15.26B | 0.25% |
GSSC | 18.70% | $520.51M | 0.2% |
FLJP | 18.54% | $1.89B | 0.09% |
AIRR | 18.45% | $3.04B | 0.7% |
BSVO | 18.37% | $1.48B | 0.47% |
IJR | 18.36% | $86.08B | 0.06% |
VIOO | 18.34% | $3.05B | 0.1% |
SPSM | 18.21% | $12.16B | 0.03% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
DBO | -0.01% | $228.06M | 0.77% |
FAN | -0.03% | $138.06M | 0.6% |
GII | 0.03% | $479.43M | 0.4% |
TPMN | 0.03% | $41.70M | 0.65% |
TDTF | 0.04% | $733.13M | 0.18% |
IBDR | 0.07% | $3.11B | 0.1% |
PCY | -0.07% | $1.27B | 0.5% |
BSCS | 0.08% | $2.29B | 0.1% |
SUSB | -0.11% | $991.46M | 0.12% |
COMT | 0.13% | $717.70M | 0.48% |
IBDS | 0.15% | $2.82B | 0.1% |
ISTB | 0.16% | $4.22B | 0.06% |
MTBA | 0.20% | $1.49B | 0.17% |
CEMB | -0.21% | $407.22M | 0.5% |
IBTI | 0.22% | $873.59M | 0.07% |
BINC | 0.22% | $6.99B | 0.4% |
VDC | -0.22% | $6.80B | 0.1% |
YYY | 0.23% | $537.78M | 4.6% |
XLV | 0.23% | $37.44B | 0.09% |
IBTG | 0.24% | $1.64B | 0.07% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BSSX | -17.59% | $63.58M | 0.18% |
UNG | -13.27% | $820.81M | 1.06% |
HIGH | -13.17% | $279.53M | 0.52% |
SHYD | -12.36% | $310.85M | 0.35% |
MMIN | -10.66% | $479.02M | 0.3% |
CGSM | -10.10% | $568.59M | 0.25% |
BSMW | -9.49% | $91.59M | 0.18% |
SMMU | -8.92% | $655.71M | 0.35% |
DFNM | -8.38% | $1.43B | 0.17% |
PWZ | -8.33% | $697.99M | 0.28% |
TAIL | -8.33% | $65.48M | 0.59% |
CORN | -8.21% | $65.39M | 0.2% |
SOYB | -8.07% | $26.14M | 0.22% |
CGMU | -8.06% | $2.68B | 0.27% |
IBMN | -7.51% | $484.21M | 0.18% |
GOVZ | -7.43% | $274.73M | 0.1% |
SUB | -7.12% | $8.67B | 0.07% |
TLT | -7.09% | $50.09B | 0.15% |
HYMB | -7.07% | $2.80B | 0.35% |
FTSL | -6.88% | $2.30B | 0.87% |